8I8.F INTERGRATED DIA.H DL 025

Healthcare Biotechnology Frankfurt Exchange
0.3840 EUR
Close of Nov 11, 2026
0.3620 0.6989
Market cap
EUR 223M
P/E
7.7x
P/B
3.48x
ROE
41.9%
Dividend yield
2.04%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 8I8.F undervalued?

Graham number
Price0.3840
Graham value0.3525
Premium8.9%

8I8.F trades 8.9% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

INTERGRATED DIA.H DL 025 fundamental analysis

No fundamental analysis for INTERGRATED DIA.H DL 025 yet.

INTERGRATED DIA.H DL 025 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About INTERGRATED DIA.H DL 025

Integrated Diagnostics Holdings plc, a consumer healthcare company, provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron emission tomography - computed tomography (PET-CT), MRI, computed tomography (CT), mammography…

Full company profile